Ajanta Pharma and Emcure Pharmaceuticals Share Price Gain After Kotak Mahindra Mutual Fund Buys Stakes

Ajanta Pharma share price and Emcure Pharmaceuticals share price remained in focus on Wednesday after Kotak Mahindra Mutual Fund acquired equity stakes in both pharmaceutical companies through separate open market transactions executed on June 9.  

The transactions involved stake purchases in Emcure Pharmaceuticals and Ajanta Pharma, with Aditya Birla Sun Life Mutual Fund also participating in the latter deal. 

Kotak Mahindra Mutual Fund Acquires Stakes in Ajanta Pharma and Emcure Pharmaceuticals 

Kotak Mahindra Mutual Fund purchased 36 lakh shares, representing a 1.89% stake, in Emcure Pharmaceuticals from BC Investments IV, an investment holding company owned by Bain Capital, for approximately ₹612 crore. The transaction was executed at ₹1,700 per share. BC Investments held a 3.87% stake in Emcure Pharmaceuticals as of March 2026. 

In a separate transaction, promoter entity Ravi Agrawal Trust sold 34.5 lakh shares, representing a 2.76% stake, in Ajanta Pharma for ₹1,023.96 crore. Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerged as buyers in the transaction. 

Kotak Mahindra Mutual Fund acquired 21.02 lakh shares worth ₹623.95 crore, while Aditya Birla Sun Life Mutual Fund purchased 13.47 lakh shares worth ₹400 crore. The transaction price for the Ajanta Pharma deal stood at ₹2,968 per share. 

Read More: SpaceX IPO: 5 Indian Mutual Funds That Can Offer Exposure to the Space Giant After Its Listing 

Ajanta Pharma Share Price Performance 

As of June 10, 2026, at 11:18 AM, Ajanta Pharma share price was trading at ₹3,077.35 on the BSE, up 2.16% from the previous close. 

The company's current market capitalisation stood at ₹38,447.06 crore. Over the last 1 year, the stock has delivered a positive return of around 20%. 

Emcure Pharmaceuticals Share Price Performance 

As of June 10, 2026, at 11:18 AM, Emcure Pharmaceuticals share price was trading at ₹1,800.90 on the BSE, up 3.34% from the previous close. 

The company's current market capitalisation stood at ₹34,153.89 crore. Over the last 1 year, the stock has delivered a positive return of around 35%. 

Conclusion 

Ajanta Pharma share price and Emcure Pharmaceuticals share price witnessed gains after Kotak Mahindra Mutual Fund increased its exposure to both pharmaceutical companies through block deals. The transactions, involving promoter and private equity stake sales, attracted institutional participation and kept both stocks in focus during Wednesday's trading session. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.   

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.